Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedVersion history updated with new entries for 2026-03-17, 2026-03, 2026-02-25, 2026-02 and Revision: v3.5.0. Older entries such as 2025-03-19, 2026-09, 2025-03-17, 2025-03 and Revision: v3.4.3 were removed.SummaryDifference0.3%

- Check24 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 banner; removed the previous government-funding operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, and a government funding/status notice was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedUI updates include adding a Show glossary option, adjusting wording for Last Update Submitted that Met QC Criteria, correcting capitalization of No FEAR Act data, and updating the Revision to v3.4.0. These are cosmetic metadata changes that do not modify study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4. This change does not affect the study data or pages beyond metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.